Literature DB >> 28127701

High-metastatic triple-negative breast-cancer variants selected in vivo become chemoresistant in vitro.

Shuya Yano1,2,3, Kiyoto Takehara1,2,3, Hiroyuki Kishimoto3, Hiroshi Tazawa4, Yasuo Urata5, Shunsuke Kagawa3, Michael Bouvet2, Toshiyoshi Fujiwara6, Robert M Hoffman7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28127701     DOI： 10.1007/s11626-016-0117-y

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN： 1071-2690            Impact factor:   2.416


× No keyword cloud information.
  8 in total

Review 1.  Triple-negative breast cancer.

Authors:  William D Foulkes; Ian E Smith; Jorge S Reis-Filho
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

2.  PARP inhibitors stumble in breast cancer.

Authors:  Malini Guha
Journal:  Nat Biotechnol       Date:  2011-05       Impact factor: 54.908

3.  Comparison of in vitro invasiveness of high- and low-metastatic triple-negative human breast cancer visualized by color-coded imaging.

Authors:  Shuya Yano; Kiyoto Takehara; Hiroshi Tazawa; Hiroyuki Kishimoto; Shunsuke Kagawa; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-10-24       Impact factor: 2.416

4.  The bulge area is the origin of nestin-expressing pluripotent stem cells of the hair follicle.

Authors:  Aisada Uchugonova; Jennifer Duong; Nan Zhang; Karsten König; Robert M Hoffman
Journal:  J Cell Biochem       Date:  2011-08       Impact factor: 4.429

5.  In Vivo Isolation of a Highly-aggressive Variant of Triple-negative Human Breast Cancer MDA-MB-231 Using Serial Orthotopic Transplantation.

Authors:  Shuya Yano; Kiyoto Takehara; Shinji Miwa; Hiroyuki Kishimoto; Hiroshi Tazawa; Yasuo Urata; Shunsuke Kagawa; Michael Bouvet; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Anticancer Res       Date:  2016-08       Impact factor: 2.480

6.  GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity.

Authors:  Sharon M Louie; Elizabeth A Grossman; Lisa A Crawford; Lucky Ding; Roman Camarda; Tucker R Huffman; David K Miyamoto; Andrei Goga; Eranthie Weerapana; Daniel K Nomura
Journal:  Cell Chem Biol       Date:  2016-05-12       Impact factor: 8.116

7.  Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro.

Authors:  B R Brinkley; P T Beall; L J Wible; M L Mace; D S Turner; R M Cailleau
Journal:  Cancer Res       Date:  1980-09       Impact factor: 12.701

8.  Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) mice with parental and subline variants of human breast cancer: implications for host defense mechanisms regulating metastasis.

Authors:  Chloe C Milsom; Christina R Lee; Christina Hackl; Shan Man; Robert S Kerbel
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240
  8 in total
  2 in total

1.  GFP labeling kinetics of triple-negative human breast cancer by a killer-reporter adenovirus in 3D Gelfoam® histoculture.

Authors:  Shuya Yano; Kiyoto Takehara; Shinji Miwa; Hiroyuki Kishimoto; Hiroshi Tazawa; Yasuo Urata; Shunsuke Kagawa; Michael Bouvet; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-02-23       Impact factor: 2.416

2.  IL-17-CXC Chemokine Receptor 2 Axis Facilitates Breast Cancer Progression by Up-Regulating Neutrophil Recruitment.

Authors:  Lingyun Wu; Mohammad Awaji; Sugandha Saxena; Michelle L Varney; Bhawna Sharma; Rakesh K Singh
Journal:  Am J Pathol       Date:  2019-10-22       Impact factor: 4.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.